Clinical Lipidology · 2010 · 12 citations · 78 references
Veterinary MedicineImmunologyPathobiologyAutoimmunityImmunopathologyInflammationCardiovascular DiseaseEndothelial ActivationEndothelial DysfunctionInflammatory MediatorsInflammatory PathologyMetabolic InflammationAntibodiesAtherosclerosis Molecular MechanismsAtherosclerotic ProgressionCellular Inflammatory ResponsesEndothelial InflammationInflammation In Cardiovascular DiseasePlaque InflammationProinflammatory Mediators
AbstractAtherosclerotic vascular disease has a wide range of clinical and pathological manifestations; nevertheless, inflammation is common in all stages of the disease. Electronegative LDL, or LDL(-), is a minimally modified form of LDL with distinct biological activities that not appear in native LDL. LDL(-) can elicit several inflammatory responses, including the induction of chemotactic or proinflammatory proteins by endothelial cells and macrophages, which contribute to atherogenesis. LDL(-) promotes atherosclerosis through inflammatory and immunologic mechanisms that lead to the production of autoantibodies and to the subsequent formation of immune complexes and macrophage foam cells. This article reviews the involvement and contribution of LDL(-) to the pathogenesis of atherosclerosis.Keywords: autoantibodybiomarkercardiovascular diseaseimmunizationinflammationminimally modified LDLrisk factor
78
Vidya Kunjathoor, Maria Febbraio, Eugene A. Podrez et al. · Journal of Biological Chemistry · 2002 · 1K citations · Full text
Protein carbamylation links inflammation, smoking, uremia and atherogenesis
Zeneng Wang, Stephen J. Nicholls, E. René Rodríguez et al. · Nature Medicine · 2007 · 704 citations
Christa Meisinger, Jens Baumert, Natalie Khuseyinova et al. · Circulation · 2005 · 435 citations · Full text
Medicine, Cardiology, Aging +12
Yury I. Miller, Suganya Viriyakosol, Christoph J. Binder et al. · Journal of Biological Chemistry · 2003 · 398 citations · Full text